AVXL
Anavex Life Sciences Corp
2.40$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
Anavex Life Sciences Corp (AVXL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -39 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.0 | -0.1 | 0.0 | -0.3 | -2.5 | -2.8 | -4.6 | -3.8 | -1.7 | -0.8 | -2.7 | -4.2 | -9.2 | -9.0 | -13 | -19 | -21 | -30 | -24 | -28 | -31 | -39 | |
| – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | |
| – | – | – | – | 1.7 | 0.8 | 0.8 | 1.3 | 0.3 | 1.0 | 0.6 | 1.6 | 5.1 | 4.1 | 5.5 | 6.4 | 4.9 | 8.2 | 18 | 16 | 9.4 | 12 | |
| – | – | – | – | – | – | – | 1.9 | – | 1.5 | 6.2 | 2.1 | 4.9 | 4.1 | 5.5 | 6.3 | 4.9 | 8.2 | 18 | 17 | – | – | |
| 0.0 | 0.0 | 0.0 | 0.5 | 0.5 | 0.0 | 0.5 | 1.2 | 2.3 | 0.5 | -0.3 | 1.2 | 0.6 | 0.4 | -0.8 | 1.3 | 0.1 | -0.7 | 5.4 | 2.5 | 2.8 | -4.2 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | – | – | – | 0.0 | 0.0 | 0.0 | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | 3.0 | – | 0.8 | 0.4 | 12 | 3.2 | 27 | 8.2 | 18 | 28 | 153 | 21 | – | – | – | |
| – | – | – | – | – | – | – | 0.7 | – | 0.3 | 9.2 | -0.1 | 0.0 | – | -0.1 | -0.1 | – | – | – | – | – | – | |
| 0.0 | 0.0 | 0.0 | 0.3 | 2.5 | 3.1 | 4.5 | 3.7 | 1.6 | 1.1 | 9.6 | 12 | 3.1 | 27 | 8.1 | 18 | 28 | 153 | 21 | 30 | 12 | 9.4 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | -0.1 | -0.1 | -0.1 | 0.3 | 6.9 | 8.0 | -6.1 | 18 | -4.5 | -0.7 | 7.1 | 123 | -3.0 | 1.9 | -19 | -30 | |
| 0.0 | -0.1 | 0.0 | -0.3 | -2.5 | -2.8 | -4.6 | -3.8 | -1.7 | -0.8 | -2.7 | -4.2 | -9.2 | -9.0 | -13 | -19 | -21 | -30 | -24 | -28 | -31 | -39 |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.